>>Proteins>> Viral Antigens>> Influenza>>4-Methylumbelliferyl-N-acetyl-α-D-Neuraminic Acid (sodium salt)

4-Methylumbelliferyl-N-acetyl-α-D-Neuraminic Acid (sodium salt) (Synonyms: 4-MUNANA, Neu5Ac-α-4MU, Sodium 2-(4-methylumbelliferyl)-N-acetylneuraminate)

Catalog No.GC42448

4-메틸움벨리페릴-N-아세틸-α-D-뉴라민산(나트륨염)은 뉴라미니다제 활성 분석에 사용되는 형광 기질입니다.

Products are for research use only. Not for human use. We do not sell to patients.

4-Methylumbelliferyl-N-acetyl-α-D-Neuraminic Acid (sodium salt) Chemical Structure

Cas No.: 76204-02-9

Size 가격 재고 수량
1mg
US$53.00
재고 있음
5mg
US$119.00
재고 있음
10mg
US$197.00
재고 있음
25mg
US$423.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

4-Methylumbelliferyl-N-acetyl-α-D-neuraminic acid is a fluorogenic substrate of neuraminidases. 4-Methylumbelliferyl-N-acetyl-α-D-neuraminic acid is cleaved by neuraminidases to release the fluorescence moiety 4-methylumbelliferyl (4-MU). 4-MU fluorescence is pH-dependent with excitation maxima of 320 and 360 nm at low (1.97-6.72) and high (7.12-10.3) pH, respectively, and an emission maximum ranging from 445 to 455 nm, increasing as pH decreases. 4-Methylumbelliferyl-N-acetyl-α-D-neuraminic acid has been used to quantify neuraminidase activity in mammalian cells and clinical isolates of influenza virus.

리뷰

Review for 4-Methylumbelliferyl-N-acetyl-α-D-Neuraminic Acid (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 17 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 4-Methylumbelliferyl-N-acetyl-α-D-Neuraminic Acid (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.